icotec's CMORE® CT System Receives NTAP Approval for Enhanced Spinal Procedures

icotec's CMORE® CT System Gains NTAP Approval

On October 7, 2026, icotec, a leading provider of radiolucent spinal implants, announced a significant milestone: the approval of an Additional Payment for New Technology (NTAP) for their CMORE® CT spinal stabilization system. This approval from the Centers for Medicare and Medicaid Services (CMS) marks a crucial step in enhancing access to innovative healthcare solutions for patients undergoing Medicare-eligible spinal procedures.

The CMORE® CT system is distinctively designed to facilitate stabilization of the cervicothoracic spine. Its revolutionary traits include radiolucent capabilities, which afford clear postoperative imaging through X-ray, CT scans, and MRIs, thereby providing healthcare practitioners with superior visualization during and after spinal surgeries.

Impact of NTAP Approval
The NTAP program, effective from October 1, 2026, aims to aid qualified hospitals in obtaining reimbursements for treatments involving the groundbreaking CMORE® CT product. This designation is particularly significant as it acknowledges technologies that meet CMS requirements, providing an additional payment for eligible hospitals utilizing these advanced solutions in their Medicare-related procedures.

Christoph Eigenmann, CEO of icotec USA, expressed his enthusiasm regarding this approval, stating, "We are thrilled that CMS has recognized our CMORE® CT system through the NTAP program, especially following its earlier designation as an Innovative Device in April 2025. This recognition provides clinicians with an approved solution to offer their patients, allowing them to 'see more' during the surgical process. Moreover, the unique properties of our BlackArmor® Carbon/PEEK material facilitate advanced therapies in the postoperative phase."

Technical Specifications and Design
The CMORE® CT system is entirely crafted from carbon/PEEK, a sophisticated non-metallic, radiolucent framework. This includes hybrid components, such as polyaxial screws and tailored rods designed to adapt perfectly to patient anatomy, addressing the needs of many spinal pathologies necessitating posterior stabilization. Notably, the CMORE® CT system stands as the only FDA-approved posterior cervicothoracic solution for treating vertebral infections, which highlights icotec’s commitment to pushing the boundaries of spinal health technology.

Through its BlackArmor® Carbon/PEEK implants, icotec combines proprietary processing techniques with advanced material science, delivering innovative and reliable solutions for spinal surgeons and their patients globally. By engaging with healthcare professionals through a multidisciplinary therapeutic approach, icotec is shaping the future of spinal implants and surgery.

For additional inquiries or details regarding the CMORE® CT system and the implications of the NTAP program, interested parties can reach out to icotec at their official email address.

As the landscape of healthcare is continually evolving, icotec’s advances in spinal technology illustrate its commitment to improving patient outcomes and embracing the future of surgical innovation. For more information on icotec and its cutting-edge products, please visit www.icotec-medical.com.